#Premarket Parabolic Curve on Positive Drug Trial

Technicals:
1. Trading 12.30 in premarket as of writing, up 57.29%
2. Price broken through all of its MA's, and has established new highs in premarket
3. MACD is currently signaling bullish
Fundamentals:
https://www.marketwatch.com/story/clearside-biomedical-shares-surge-53-premarket-on-news-of-positive-trial-of-eye-disease-treatment-2018-03-05?siteid=yhoof2&yptr=yahoo
—
For the complete technical analysis on this swing trading set-up, including full price extensions and bullish/bearish targets, click here: compoundtrading.com/swing-trading-periodical-contact
1. Trading 12.30 in premarket as of writing, up 57.29%
2. Price broken through all of its MA's, and has established new highs in premarket
3. MACD is currently signaling bullish
Fundamentals:
https://www.marketwatch.com/story/clearside-biomedical-shares-surge-53-premarket-on-news-of-positive-trial-of-eye-disease-treatment-2018-03-05?siteid=yhoof2&yptr=yahoo
—
For the complete technical analysis on this swing trading set-up, including full price extensions and bullish/bearish targets, click here: compoundtrading.com/swing-trading-periodical-contact
Founder: EPIC Agentic AI | World's Best Autonomous Trading Software
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Founder: EPIC Agentic AI | World's Best Autonomous Trading Software
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
dashboard.epicaitrader.com | epicaihub.io
Trading CL_F, NQ_F, BTC, ETH, SOL, TAO, SUI, XRP, Stock Basket
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.